Literature DB >> 1451704

Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.

G Lucignani1, G Paolini, C Landoni, M Zuccari, G Paganelli, L Galli, G Di Credico, G Vanoli, C Rossetti, M A Mariani.   

Abstract

We tested the possibility of identifying areas of hibernating myocardium by the combined assessment of perfusion and metabolism using single photon emission tomography (SPET) with technetium-99m hexakis 2-methoxyisobutylisonitrile (99mTc-MIBI) and positron emission tomography (PET) with fluorine-18 fluoro-2-deoxy-D-glucose (18F-FDG). Segmental wall motion, perfusion and 18F-FDG uptake were scored in 5 segments in 14 patients with coronary artery disease (CAD), for a total number of 70 segments. Each subject underwent the following studies prior to and following coronary artery bypass grafting (CABG): first-pass radionuclide angiography, electrocardiography gated planar perfusion scintigraphy and SPET perfusion scintigraphy with 99mTc-MIBI and, after 16 h fasting, 18F-FDG/PET metabolic scintigraphy. Wall motion impairment was either decreased or completely reversed by CABG in 95% of the asynergic segments which exhibited 18F-FDG uptake, whereas it was unmodified in 80% of the asynergic segments with no 18F-FDG uptake. A stepwise multiple logistic analysis was carried out on the asynergic segments to estimate the postoperative probability of wall motion improvement on the basis of the preoperative regional perfusion and metabolic scores. The segments with the highest probability (96%) of functional recovery from preoperative asynergy after revascularization were those with a marked 18F-FDG uptake prior to CABG. High probabilities of functional recovery were also estimated for the segments presenting with moderate and low 18F-FDG uptake (92% and 79%, respectively). A low probability of functional recovery (13%) was estimated in the segments with no 18F-FDG uptake.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451704     DOI: 10.1007/bf00168164

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  28 in total

Review 1.  The clinical role of metabolic imaging of the heart by positron emission tomography.

Authors:  M Schwaiger; R Hicks
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

Review 2.  PET perfusion imaging and nuclear cardiology.

Authors:  K L Gould
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

3.  Myocardial viability. What does it mean and how do we measure it?

Authors:  K L Gould
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

4.  Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors.

Authors:  N A Mullani; R A Goldstein; K L Gould; S K Marani; D J Fisher; H A O'Brien; M D Loberg
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

5.  Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose.

Authors:  K Yamada; S Endo; H Fukuda; Y Abe; S Yoshioka; M Itoh; K Kubota; J Hatazawa; T Satoh; T Matsuzawa
Journal:  Eur J Nucl Med       Date:  1985

6.  The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.

Authors:  J J Berry; J A Baker; K S Pieper; M W Hanson; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

7.  Simultaneous assessment of left ventricular wall motion and myocardial perfusion with technetium-99m-methoxy isobutyl isonitrile at stress and rest in patients with angina: comparison with thallium-201 SPECT.

Authors:  J Villanueva-Meyer; I Mena; K A Narahara
Journal:  J Nucl Med       Date:  1990-04       Impact factor: 10.057

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  Quantification of regional myocardial blood flow in vivo with H215O.

Authors:  S R Bergmann; K A Fox; A L Rand; K D McElvany; M J Welch; J Markham; B E Sobel
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

10.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Authors:  K Hamacher; H H Coenen; G Stöcklin
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

View more
  32 in total

1.  Evaluation of left ventricular wall motion, volumes, and ejection fraction by gated myocardial tomography with technetium 99m-labeled tetrofosmin: a comparison with cine magnetic resonance imaging.

Authors:  P Vaduganathan; Z X He; G W Vick; J J Mahmarian; M S Verani
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

3.  Factors influencing predictive value of FDG imaging for evaluating myocardial viability.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

Review 4.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

Review 5.  Radionuclide techniques for the assessment of myocardial viability.

Authors:  E Skoufis; A I McGhie
Journal:  Tex Heart Inst J       Date:  1998

Review 6.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

7.  Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery.

Authors:  P Marzullo; G Sambuceti; O Parodi; A Gimelli; E Picano; A Giorgetti; A L'Abbate
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

8.  Clinical cardiac PET: quo vadis?

Authors:  H R Schelbert; J Maddahi
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

9.  The suitability of gamma camera coincidence systems for nitrogen 13-labeled ammonia myocardial perfusion imaging: a quantitative comparison with full-ring PET.

Authors:  Fergus I McKiddie; Howard G Gemmell; E Joyce Davidson; Andrew Welch; Mohaned Egred
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

Review 10.  Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.

Authors:  Shahbudin H Rahimtoola; Vasken Dilsizian; Christopher M Kramer; Thomas H Marwick; Jean-Louis J Vanoverschelde
Journal:  JACC Cardiovasc Imaging       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.